Medicinal composition for treating diabetes mellitus

The technology of a composition and medicine is applied to the pharmaceutical composition of type II diabetes and the preparation thereof, the pharmaceutical composition for the treatment of diabetes and the field of preparation thereof, which can solve the problems of impaired insulin secretion and the like, achieve less recurrence, better hypoglycemia, The effect of reducing the economic burden

Inactive Publication Date: 2012-06-13
高芹凤
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Unfortunately, β-cell dysfunction results in impaired insulin secretion that is progressively worse

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] A pharmaceutical composition for treating type 2 diabetes, which is prepared from the following raw materials in proportion by weight:

[0026] Ophiopogon japonicus 20, Scutellaria baicalensis 18, Yam 18, Angelica 16, Anemarrhena 15, Japonica rice 12, Licorice 12, Astragalus 10, Atractylodes macrocephala 9, Paeoniae Alba 8, Black plum 7, Pueraria 6, Rehmannia glutinosa 6, Schisandra 4, Ginseng 4.

[0027] The preparation method of the above-mentioned pharmaceutical composition comprises the following steps: taking the above-mentioned raw materials in various parts by weight for use; After drying, pulverize into 80-mesh medicinal powder, pack into capsules, and sterilize to obtain capsule preparations.

[0028] Dosage form and usage: The dosage form of this prescription is capsule dosage form, three times a day, take half an hour before meals, 2 capsules each time, 0.5g per capsule, two weeks as a course of treatment.

Embodiment 2

[0030] zoology experiment

[0031] Experimental animals: 40 SD rats, half male and half female, weighing 160-180 g, provided by the Animal Center of Linyi People's Hospital. After the rats were adapted to feeding in the animal room for 5 days, 8 rats were randomly selected as the normal control group and fed with ordinary maintenance feed. High-sugar and high-fat feed formula: rat basic feed 68%, sucrose 10%, egg yolk powder 9%, lard 8%, cholesterol 1%, bile salt 0.2%.

Embodiment approach

[0032] Implementation method: the remaining 32 were fed with high-sugar and high-fat diet for 4 weeks. Four weeks later, rats were fasted for 24 hours, and streptozotocin (STZ) was injected intravenously at 20 mg / Kg once every two days. Choose 24 successful rats of modeling, be divided into 3 groups at random, 8 in every group, i.e. model group (do not use any medicine), the embodiment of the present invention 1 medicine group 10mg / Kg, contrast medicine group: use metformin hydrochloride ( 10mg / kg), the way of administration is oral, and it is taken half an hour before meals every day. Tested after 10 days of continuous use.

[0033] Statistical analysis: The data are represented by x ± s, and SPSS17.0 statistical software is used for data analysis. The comparison between multiple groups is by analysis of variance, and the comparison between two groups is by t test. P<0.05 is statistically significant.

[0034] Treatment effect: The biochemical indicators of fasting plasma ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicinal composition for treating type II diabetes mellitus. The medicinal composition is prepared from the following raw materials in parts by weight: 18-22 parts of dwarf lilyturf root, 16-20 parts of baikal skullcap root, 16-20 parts of Chinese yam, 14-18 parts of Chinese angelica, 14-17 parts of common anemarrhena, 10-14 parts of polished round-grained rice, 10-14 parts of liquoric root, 8-12 parts of astragalus, 9-11 parts of large-head atractylodes rhizome, 7-9 parts of white paeony root, 6-8 parts of dark plum fruit, 5-7 parts of kudzuvine root, 5-7 parts ofprepared rehmannia, 3-5 parts of Chinese magnoliavine fruit and 3-5 parts of ginseng. The medicinal composition has the advantages of short treatment course, high total effective rate, prevention of relapse after curing, simple process, reduction in production cost and lowering of the economic burden of a patient.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to a pharmaceutical composition for treating diabetes and a preparation method thereof, in particular to a type II diabetes pharmaceutical composition and a preparation method thereof. Background technique [0002] Diabetes (diabetes) is a sugar, protein, A series of metabolic disorder syndromes such as fat, water and electrolytes are clinically characterized by hyperglycemia. In typical cases, polyuria, polydipsia, polyphagia, weight loss and other manifestations may appear, namely "three excesses and one deficiency" symptoms. Diabetes ( Once the blood sugar is not well controlled, it will cause complications, leading to failure and lesions of the kidneys, eyes, feet and other parts, which cannot be cured. Clinical observation Insulin resistance is common in type Ⅱ diabetes, up to about 90%. Type 2 diabetes, also known as non-insulin-dependent diabetes mellitus (N...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P3/10
Inventor 高芹凤王春霞
Owner 高芹凤
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap